Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00208975
Status:
TERMINATED
Last Update Posted:
2012-06-28
First Post:
2005-09-13
Brief Title:
Phase II Study of Fludarabine and Mitoxantrone Followed by GM-CSFGranulocyte-macrophage Colony-stimulating Factor and Rituximab
Sponsor:
Emory University
Organization:
Emory University
Organization Data
Organization:
Emory University
Class:
OTHER
Study ID:
1048-2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Emory University
Lead Sponsor Class:
OTHER
Responsible Party:
Christopher R Flowers
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Emory University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |